Remove 2030 Remove Clinical Development Remove Clinical Research
article thumbnail

The Costs of Working with a CRO

Vial

According to a report by Grand View Research, the global CRO services market was valued at approximately US$50.55 from 2024 to 2030. Ultimately, conducting an informed review of these cost factors will ensure companies make the best decision for their clinical development and operational needs.

article thumbnail

Best-in-Class Solutions Accelerate Development of GLP-1 Therapeutics

PPD

Food and Drug Administrations (FDA) diversity and inclusion in clinical trials mandate. However, it is representative of the average across most of todays trials, where only 2030% of participants are women. Were applying that expertise and commitment to every aspect of developing and running successful GLP-1 studies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Year Ahead: 2023 Trends Shaping Diagnostics & Life Sciences

PerkinElmer

To help make more timely and informed clinical candidate decisions going forward, scientists need to be able to securely, intuitively, and quickly find, analyze and share critical discovery-stage data, as well as do reliable predictive analysis. These same challenges and needs also extend from research and discovery to clinical development.

Science 52
article thumbnail

Five Key Trends Shaping Biopharma and Biotech in 2025

PPD

To better understand current challenges and their impact, the PPD clinical research business of Thermo Fisher Scientific surveyed global drug developers on the current state of the industry. These pressures are prompting companies to reevaluate their portfolios, focusing on investments that promise the greatest impact.